Microbubble-Enabled Isolation Kit
Akadeum’s Life Sciences isolation kit uses microbubbles to reduce leukopak production time.
Akadeum Life Sciences’ Microbubble Leukopak Human T-Cell Isolation Kit
Akadeum Life Sciences’ Microbubble Leukopak Human T-Cell Isolation kit is a research-use-only kit developed to address various biological and workflow challenges in large-volume cell separation workflows. The kit uses a technology combining microbubbles with a buoyancy-activated cell sorting separation tube to produce nearly two leukopaks,which are blood bags containing billions of white blood cells, in one hour.
Akadeum’s patented microbubble technology uses low-density particles to float targeted cells to the top of a sample. In addition to reducing the time necessary to produce leukopaks, the technology is also designed to promote the health and physiology of the
cells, allow for minimal handling, increase throughput, and enable less pre-processing.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
